Covid vaccine from Germany’s CureVac just 48% effective

Germany's CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna.

from Latest News and News Headlines | Daily Telegraph https://ift.tt/3hoH8bz
https://ift.tt/eA8V8J